193 related articles for article (PubMed ID: 35117877)
1. Radiation therapy for primary tumor of
Yoshimura M
Transl Cancer Res; 2020 Aug; 9(8):5108-5116. PubMed ID: 35117877
[TBL] [Abstract][Full Text] [Related]
2. Identifying the optimal candidates for locoregional radiation therapy in patients with de novo metastatic nasopharyngeal carcinoma.
Xu H; Lu L; Lu T; Xu Y; Zong J; Huang C; Lin F; Zheng Y; Lin C; Lin S; Qiu S; Pan J; Lin S; Guo Q
Head Neck; 2021 Sep; 43(9):2602-2610. PubMed ID: 33904617
[TBL] [Abstract][Full Text] [Related]
3. Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein-Barr virus DNA level and tumor response to palliative chemotherapy.
Sun XS; Liu LT; Liu SL; Guo SS; Wen YF; Xie HJ; Tang QN; Liang YJ; Li XY; Yan JJ; Ma J; Chen QY; Tang LQ; Mai HQ
BMC Cancer; 2019 Jan; 19(1):92. PubMed ID: 30665378
[TBL] [Abstract][Full Text] [Related]
4. Effective of metastasis-directed therapy for de novo metastatic nasopharyngeal carcinoma: A propensity score matched analysis.
Liu GY; Li Z; Chen XX; Xia WX; Yao HR; Xiang YQ
Head Neck; 2023 Oct; 45(10):2571-2579. PubMed ID: 37554098
[TBL] [Abstract][Full Text] [Related]
5. Effects of locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A real-world study.
Zeng F; Lu T; Xie F; Chen L; Zhang L; Su Y; Yu Z; Xiao Y; Ao F; Li G; Chen Z; Gong X; Li J
Transl Oncol; 2021 Nov; 14(11):101187. PubMed ID: 34365221
[TBL] [Abstract][Full Text] [Related]
6. Locoregional Treatment of the Primary Tumor in Patients With De Novo Stage IV Breast Cancer: A Radiation Oncologist's Perspective.
Choi SH; Kim JW; Choi J; Sohn J; Kim SI; Park S; Park HS; Jeong J; Suh CO; Keum KC; Kim YB; Lee IJ
Clin Breast Cancer; 2018 Apr; 18(2):e167-e178. PubMed ID: 28689012
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Survival of De Novo Stage IV Human Epidermal Growth Receptor 2 (HER2) Positive Breast Cancers Treated with HER2-Targeted Therapy.
Wong Y; Raghavendra AS; Hatzis C; Irizarry JP; Vega T; Horowitz N; Barcenas CH; Chavez-MacGregor M; Valero V; Tripathy D; Pusztai L; Murthy RK
Oncologist; 2019 Mar; 24(3):313-318. PubMed ID: 30139836
[TBL] [Abstract][Full Text] [Related]
8. Optimizing the Treatment Pattern for
Sun XS; Liang YJ; Chen QY; Guo SS; Liu LT; Sun R; Luo DH; Tang LQ; Mai HQ
Front Oncol; 2020; 10():543646. PubMed ID: 33194602
[TBL] [Abstract][Full Text] [Related]
9. Second malignancies after adjuvant radiation therapy for early stage breast cancer: is there increased risk with addition of regional radiation to local radiation?
Hamilton SN; Tyldesley S; Li D; Olson R; McBride M
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):977-85. PubMed ID: 25832690
[TBL] [Abstract][Full Text] [Related]
10. Locoregional treatment of
Merloni F; Palleschi M; Gianni C; Casadei C; Curcio A; Romeo A; Rocchi M; Cima S; Sirico M; Sarti S; Cecconetto L; Mariotti M; Di Menna G; De Giorgi U
Front Oncol; 2023; 13():1083297. PubMed ID: 36793604
[TBL] [Abstract][Full Text] [Related]
11. A prognostic scoring model for survival after locoregional therapy in de novo stage IV breast cancer.
Kommalapati A; Tella SH; Goyal G; Ganti AK; Krishnamurthy J; Tandra PK
Breast Cancer Res Treat; 2018 Aug; 170(3):677-685. PubMed ID: 29721715
[TBL] [Abstract][Full Text] [Related]
12. Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy.
Yang JH; Sun XS; Xiao BB; Liu LT; Guo SS; Liang JD; Jia GD; Tang LQ; Chen QY; Mai HQ
BMC Cancer; 2021 May; 21(1):534. PubMed ID: 33975558
[TBL] [Abstract][Full Text] [Related]
13. Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis.
Reinhorn D; Mutai R; Yerushalmi R; Moore A; Amir E; Goldvaser H
Breast; 2021 Aug; 58():173-181. PubMed ID: 34158167
[TBL] [Abstract][Full Text] [Related]
14. Role of Locoregional Treatment in De Novo Stage IV Breast Cancer.
Lee JS; Toktas O; Soran A
Clin Med Insights Oncol; 2020; 14():1179554920942440. PubMed ID: 32994701
[TBL] [Abstract][Full Text] [Related]
15. Effect of local surgery on outcomes of stage IV breast cancer.
Tsukioki T; Shien T; Doihara H
Transl Cancer Res; 2020 Aug; 9(8):5102-5107. PubMed ID: 35117876
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy.
Rossi V; Nolè F; Redana S; Adamoli L; Martinello R; Aurilio G; Verri E; Sapino A; Viale G; Aglietta M; Montemurro F
Breast; 2014 Feb; 23(1):44-9. PubMed ID: 24210572
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of Curative-Intent Treatment for Patients With Breast Cancer Presenting With Sternal or Mediastinal Involvement.
Christopherson K; Lei X; Barcenas C; Buchholz TA; Garg N; Hoffman KE; Kuerer HM; Mittendorf E; Perkins G; Shaitelman SF; Smith GL; Stauder M; Strom EA; Tereffe W; Woodward WA; Smith BD
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):574-581. PubMed ID: 30851348
[TBL] [Abstract][Full Text] [Related]
18. Impact of Primary Site Surgery on Survival of Patients with de novo Stage IV Breast Cancer.
Huang Z; Tan Q; Qin Q; Mo Q; Wei C
Cancer Manag Res; 2021; 13():319-327. PubMed ID: 33469374
[TBL] [Abstract][Full Text] [Related]
19. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
20. Locoregional therapy of the primary tumour in de novo stage IV breast cancer in 216 066 patients: A meta-analysis.
Gera R; Chehade HELH; Wazir U; Tayeh S; Kasem A; Mokbel K
Sci Rep; 2020 Feb; 10(1):2952. PubMed ID: 32076063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]